Cellect Biotechnology Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing covers the month of January 2017 for Cellect Biotechnology Ltd., a foreign private issuer headquartered in Kfar Saba, Israel. The filing reports on corporate governance events rather than financial performance.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on shareholder meeting logistics.
Material Changes
On January 9, 2017, the Company convened an extraordinary general meeting of ordinary shareholders, ADS holders, and Series-1 Stock Option holders. Due to a lack of quorum for both groups, all meetings were adjourned for one week.
Outlook and Management Commentary
Management has scheduled reconvened meetings for Monday, January 16, 2017, at the offices of the Company's attorneys in Ramat Gan, Israel:
- Ordinary shareholders and ADS holders: 3:00 p.m.
- Series-1 Stock Option holders: 3:30 p.m.
No specific guidance, risks, or unusual financial items were disclosed in this document.
Investor Verification Checklist
- Verify the outcome of the reconvened meetings scheduled for January 16, 2017.
- Confirm whether a quorum was achieved at the rescheduled sessions.
- Review subsequent filings for the results of the votes intended for the original January 9 meeting.